Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Cannabis businesses in New York are growing increasingly frustrated over counterfeiting. Cheddar News spoke with Peter Tang, founder of Plugplay and Dr. Nima Majlesi of Staten Island University Hospital about the effects of counterfeiting.
